» Articles » PMID: 21442413

Anti-oxidant, Anti-inflammatory and Immunomodulating Properties of an Enzymatic Protein Hydrolysate from Yellow Field Pea Seeds

Overview
Journal Eur J Nutr
Date 2011 Mar 29
PMID 21442413
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Enzymatic protein hydrolysates of yellow pea seed have been shown to possess high anti-oxidant and anti-bacterial activities. The aim of this work was to confirm the anti-oxidant, anti-inflammatory and immunomodulating activities of an enzymatic protein hydrolysate of yellow field pea seeds.

Methods: The anti-oxidant and anti-inflammatory properties of peptides from yellow field pea proteins (Pisum sativum L.) were investigated in LPS/IFN-γ-activated RAW 264.7 NO⁻ macrophages. The immunomodulating potential of pea protein hydrolysate (PPH) was then studied in a murine model.

Results: Pea protein hydrolysate, after a 12 h pre-treatment, showed significant inhibition of NO production by activated macrophages up to 20%. Moreover, PPH significantly inhibited their secretion of pro-inflammatory cytokines, TNF-α- and IL-6, up to 35 and 80%, respectively. Oral administration of PPH in mice enhanced the phagocytic activity of their peritoneal macrophages and stimulated the gut mucosa immune response. The number of IgA+ cells was elevated in the small intestine lamina propria, accompanied by an increase in the number of IL-4+, IL-10+ and IFN-γ+ cells. This was correlated to up-regulation of IL-6 secretion by small intestine epithelial cells (IEC), probably responsible for B-cell terminal differentiation to IgA-secreting cells. Moreover, PPH might have increased IL-6 production in IECs via the stimulation of toll-like receptors (TLRs) family, especially TLR2 and TLR4 since either anti-TLR2 or anti-TLR4 was able to completely abolish PPH-induced IL-6 secretion.

Conclusions: Enzymatic protein degradation confers anti-oxidant, anti-inflammatory and immunomodulating potentials to pea proteins, and the resulted peptides could be used as an alternative therapy for the prevention of inflammatory-related diseases.

Citing Articles

Quinoa Protein Hydrolysate as Potential Immunomodulators: Effects on Cytokine Production and Macrophage Activation.

Rueda J, Galdeano C, Lobo M, Samman N Plant Foods Hum Nutr. 2025; 80(1):73.

PMID: 39985604 DOI: 10.1007/s11130-025-01324-9.


Nutritional, Antibacterial and Thrombolytic Prospects of Freshwater Protein Hydrolysate and Its Anti-Inflammatory Potential in LPS-Induced RAW 264.7 Macrophage Cells.

Siddique T, Rafi K, Akter S, Bithy F, Aktar R, Khan A Food Sci Nutr. 2025; 13(1):e4711.

PMID: 39803236 PMC: 11717026. DOI: 10.1002/fsn3.4711.


Unlocking the Nutraceutical Potential of Legumes and Their By-Products: Paving the Way for the Circular Economy in the Agri-Food Industry.

Guo F, Danielski R, Santhiravel S, Shahidi F Antioxidants (Basel). 2024; 13(6).

PMID: 38929075 PMC: 11201070. DOI: 10.3390/antiox13060636.


Efficacy and Tolerability of a Novel Topical Treatment Containing Pea Protein and Xyloglucan in the Management of Atopic Dermatitis in Children: A Prospective, Multicenter Clinical Study.

Sowlati M, Morariu S, Orzan O, Veraldi S, Dodiuk-Gad R, Orasan R Dermatol Ther (Heidelb). 2023; 13(11):2669-2679.

PMID: 37740857 PMC: 10613178. DOI: 10.1007/s13555-023-01035-6.


Topical Application of a Formulation Containing Pea Proteins and Xyloglucan in Adult Patients with Atopic Dermatitis: A Double-blind, Parallel, Randomized, Placebo-controlled, Multicenter Study.

Sowlati M, Orzan O, Morariu S, Etropolska Z, Veraldi S, Dimitrov S J Clin Aesthet Dermatol. 2023; 16(7):35-41.

PMID: 37560506 PMC: 10409507.


References
1.
Bhattacharyya S, Gill R, Chen M, Zhang F, Linhardt R, Dudeja P . Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. J Biol Chem. 2008; 283(16):10550-8. PMC: 2447641. DOI: 10.1074/jbc.M708833200. View

2.
Levi R, Sanderson I . Dietary regulation of gene expression. Curr Opin Gastroenterol. 2005; 20(2):139-42. DOI: 10.1097/00001574-200403000-00015. View

3.
Vinderola G, Perdigon G, Duarte J, Farnworth E, Matar C . Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity. Cytokine. 2007; 36(5-6):254-60. DOI: 10.1016/j.cyto.2007.01.003. View

4.
Gonzalez de Mejia E, Dia V . Lunasin and lunasin-like peptides inhibit inflammation through suppression of NF-kappaB pathway in the macrophage. Peptides. 2009; 30(12):2388-98. DOI: 10.1016/j.peptides.2009.08.005. View

5.
Sanderson I, Naik S . Dietary regulation of intestinal gene expression. Annu Rev Nutr. 2000; 20:311-38. DOI: 10.1146/annurev.nutr.20.1.311. View